US2011257380A1PendingUtilityA1
Glycomimetic replacements for hexoses and n-acetyl hexosamines
Est. expiryOct 12, 2026(~0.2 yrs left)· nominal 20-yr term from priority
C07H 15/207A61P 43/00
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds and methods are provided for obtaining oligosaccharide mimics. More specifically, compounds and methods are described wherein oligosaccharide mimics are obtained by incorporating or substituting in a cyclohexane derivative.
Claims
exact text as granted — not AI-modified1 .- 3 . (canceled)
4 . A compound comprising:
R 1 ═H, C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, halogenated C 1 -C 8 alkanyl, aryl or heteroaryl either of which may be substituted with one or more of Me, OMe, halide, OH, or NHX where X═H, C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, halogenated C 1 -C 8 alkanyl, aryl or heteroaryl either of which may be substituted with one or more of Me, OMe, halide, or OH; C(═O)OX, alkanyl substituted with C(═O)OX, C(═O)NHX, alkanyl substituted with C(═O)NHX, where X═C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, halogenated C 1 -C 8 alkanyl, aryl or heteroaryl either of which may be substituted with one or more of Me, OMe, halide, or OH; NHX, where X═H, C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, halogenated C 1 -C 8 alkanyl, aryl or heteroaryl either of which may be substituted with one or more of Me, OMe, halide, or OH;
R 2 ═H, C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, halogenated C 1 -C 8 alkanyl, aryl or heteroaryl either of which may be substituted with one or more of Me, OMe, halide, OH, or NHX where X═H, C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, halogenated C 1 -C 8 alkanyl, aryl or heteroaryl either of which may be substituted with one or more of Me, OMe, halide, or OH; —C(═O)OX where X is C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, aryl or heteroaryl either of which may be substituted with one or more of Me, OMe, halide, or OH; —C(═O)NH(CH 2 ) n NH 2 where n=0-30, C(═O)NHX or CX 2 OH, where X═C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, halogenated C 1 -C 8 alkanyl, aryl or heteroaryl either of which may be substituted with one or more of Me, OMe, halide, or OH; OX, NHX, NH(═O)X, where X═H, C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, halogenated C 1 -C 8 alkanyl, aryl or heteroaryl either of which may be substituted with one or more of Me, OMe, halide, or OH; with the proviso that R 1 and R 2 are not both H;
R 3 ═—OH,
—O—C(═O)—X, —NH 2 , —NH—C(═O)—NHX, or —NH—C(═O)—X where n=0-2 and X is independently selected from C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl,
where Q is H or a physiologically acceptable cation, C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, aryl, heteroaryl, (CH 2 ) m -aryl or (CH 2 ) m -heteroaryl where m is 1-10, and where n=0-10, and any of the above ring compounds may be substituted with one to three independently selected of Cl, F, CF 3 , C 1 -C 8 alkoxy, NO 2 , C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, C 1 -C 14 aryl, or OY, C(═O)OY, NY 2 or C(═O)NHY where Y is H, C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, or C 1 -C 14 aryl;
where R 9 is aryl, heteroaryl, cyclohexane, t-butane, adamantane, or triazole, and any of R 9 may be substituted with one to three independently selected of Cl, F CF 3 , C 1 -C 8 alkoxy, NO 2 , C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl or OY, C(═O)OY, NY 2 or C(═O)NHY where Y is H, C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, and C 1 -C 8 alkynyl or C 1 -C 14 aryl; and where R 10 is one of
where Q is H or a physiologically acceptable cation, C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, aryl, heteroaryl, (CH 2 ) m -aryl or (CH 2 ) m -heteroaryl where m is 1-10, n=1-4, Z and Y═C 1 -C 8 alkanyl, C 1 -C 8 alkenyl, C 1 -C 8 alkynyl, halogenated C 1 -C 8 alkanyl, aryl and heteroaryl substituted with Me, OMe, halide, OH; and
R 5 ═H, D-mannose, L-galactose, D-arabinose, L-fucose, polyols.
5 . A compound consisting of the compound of claim 4 .
6 .- 17 . (canceled)
18 . The compound according to claim 5 having the formula:
where Me is methyl, Et is ethyl and Bz is benzoyl.
19 . The compound according to claim 5 having the formula:
where Me is methyl and Bz is benzoyl.
20 . The compound according to claim 5 having the formula:
where Me is methyl, Et is ethyl and Bz is benzoyl.
21 . The compound according to claim 5 having the formula:
where Me is methyl and Bz is benzoyl.
22 . The compound according to claim 4 with polyethylene glycol attached thereto.
23 . The compound according to claim 4 attached to another of the compound according to claim 4 by polyethylene glycol.
24 . The compound according to claim 5 with polyethylene glycol attached thereto.
25 . The compound according to claim 5 attached to another of the compound according to claim 5 by polyethylene glycol.Join the waitlist — get patent alerts
Track US2011257380A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.